Tokyo

London

New York

Register

Sign In

EUR/USD

1.1664

0.0036

0.31%

GBP/USD

1.2995

0.0029

0.23%

USD/JPY

111.13

-0.7425

-0.66%

USD/CHF

0.9459

-0.0056

-0.59%

EUR/GBP

0.8976

0.0008

0.08%

USD/CAD

1.2542

-0.0054

-0.43%

NZD/USD

0.7455

0.0052

0.71%

EUR/JPY

129.61

-0.4680

-0.36%

EUR/CHF

1.1033

-0.0031

-0.28%

Aevi Genomic Medicine

NASDAQ: GNMXHealthcare / Biotechnology / USA
1.29-0.03-2.27%Vol 55 2201Y Perf -77.49%
Jul 21st, 2017 16:00
BID1.29 ASK1.34
Open1.31 Previous Close1.32
Pre-Market- After-Trading-
 - -%  - -%
Target Price
6.90 
Analyst Rating
Moderate Buy 1.75
Potencial %
434.88 
Finscreener Ranking
—    -
Insiders Trans % 3/6/12M
100/100/100 
Value Ranking
—    -
Insiders Value % 3/6/12M
100/100/100 
Growth Ranking
—    -
Insiders Shares Cnt. % 3/6/12M
100/100/100 
Income Ranking
—    -
Market Cap (mil)49 
Earnings Rating
Buy
Price Range Ratio 52wk %
5.25 
Earnings Date
3rd Aug 2017

Today's Price Range

1.281.35

 

52wk Range

0.986.89

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Month
-7.04%
3 Months
-29.03%
6 Months
-73.06%
1 Year
-77.49%
3 Years
-
5 Years
-
Last Quotes
Name / TickerPriceChg.Chg.%
GNMX1.29-0.0300-2.27
AAPL150.27-0.0700-0.05
GOOG972.924.77000.49
MSFT73.79-0.4300-0.58
XOM80.12-0.7400-0.92
WFC54.17-0.7100-1.29
JNJ135.31-1.2600-0.92
FB164.43-0.1000-0.06
GE25.91-0.7800-2.92
JPM90.89-0.3100-0.34
...

TickerPriceChg.%52 Week High
CTAS138.439.19139.39
COF87.948.5596.92
ETFC41.635.1341.83
SYF30.874.5438.06
MCO132.574.25133.62
FITB26.182.7128.97
NFLX188.542.69191.50
KMX66.092.6669.11
VRTX163.172.41167.00
AAP105.271.98177.83
CCI99.171.95104.68
DFS62.531.8974.33
AEP69.981.8672.97
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 5.40
Current Ratio 5.50
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage -10 029.50
Leverage Ratio 1.20
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-
EBITDA Margin-
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 1.97
PS Ratios -
Price to Cash Flow -
Price to Free Cash Flow -2.00
Cash Flow Per Share -0.95
Price to Tangible Book1.97
Book Value per Share0.68
Enterprise Value (in ths.)20 153
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-110.04
ROE last 12 Months -130.17
Return on Assets (5Y Avg) -66.69
ROA last 12 Months -114.47
Return on Capital (5Y Avg) -211.32
ROC last 12 Months -124.99
Return on invested Capital Q -36.35
Return on invested Capital Y-98.24
Assets Turnover-
Receivables Turnover-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)-
Revenue per Share -
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q01 2017-0.27-0.29-7.41
Q04 2016-0.31-0.2229.03
Q03 2016-0.32-0.299.38
Q02 2016-0.32-0.35-9.38
Q01 2016-0.29-0.34-17.24
Q04 2015-0.27-0.257.41
Q03 2015-0.31-0.33-6.45
Q02 2015-0.34-0.2817.65
Earnings Per EndEstimateRevision %Trend
6/2017 QR-0.263.70Positive
9/2017 QR-0.263.70Positive
12/2017 FY-1.104.35Positive
12/2018 FY-1.46-3.55Negative
Next Report Date3rd Aug 2017
Estimated EPS Next Report-0.26
Estimates Count3
EPS Growth Next 5 Years %0.00
Volume Overview
Volume55 220
Shares Outstanding (in ths.)37 110
Trades Count140
Dollar Volume69 395
Avg. Volume555 046
Avg. Weekly Volume125 424
Avg. Monthly Volume400 456
Avg. Quarterly Volume394 103

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

100%0%

Bearish Bullish

100%0%

Bearish Bullish

100%0%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (50.00 %)
2 (50.00 %)
2 (50.00 %)
Moderate Buy
1 (25.00 %)
1 (25.00 %)
1 (25.00 %)
Hold
1 (25.00 %)
1 (25.00 %)
1 (25.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
1.75
Moderate Buy
1.75
Moderate Buy
1.75

There are no comments yet.

News

Plus500
x